Drug major Ranbaxy today reported a net loss after tax and minority interest of Rs 464.58 crore for the quarter ended September 30, 2011, on account of foreign exchange losses.
The company had posted a net profit of Rs 307.93 crore for the quarter ended September 30, 2010, Ranbaxy Laboratories said.
Net sales of the company stood at Rs 2,022.75 crore in the quarter ended September 30, 2011, compared to Rs 1,877.48 crore in the same period of the previous fiscal.
Shares of Ranbaxy laboratories were being quoted at Rs 481 per share in afternoon trade on the BSE today, down 3.18% from their previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app